Pharma IQ spoke to Bhuvaneish T. Selvaraj, a Post Doctorate Fellow in neurodegenerative disorders, to discover more about his ongoing CRISPR Cas9 project.
|
Have Your Say Rate this feature and give us your feedback in the comments section below |